| Dr Lonnie Edward Dye Iii, MD | |
|
820 N Chelan Ave, Wenatchee, WA 98801-2028 | |
| (509) 662-1511 | |
| Not Available |
| Full Name | Dr Lonnie Edward Dye Iii |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 14 Years |
| Location | 820 N Chelan Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366762924 | NPI | - | NPPES |
| 100034366 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD61360173 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Washington Hospital | Wenatchee, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Washington Health Services Association | 4880504596 | 645 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
Affimed Therapeutics AG and The Leukemia & Lymphoma Society today announced a partnership to co-fund a phase 2 trial with the Recruit-TandAb AFM13, a novel tetravalent bispecific antibody directed against human CD30 and CD16A in Hodgkin Lymphoma patients for whom currently available treatments have failed.
Loads of studies over the years have shown that children who were breastfed score higher on IQ tests and perform better in school, but the reason why remained unclear.
Fewer Americans fear root canal treatment, according to a recent survey by the American Association of Endodontists. Just over half of those surveyed, 54 percent, said root canals make them apprehensive, down from 60 percent in 2013, and the lowest numbers reported since the AAE began its annual survey in 2011.
› Verified 7 days ago
| Entity Name | Central Washington Health Services Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801937453 PECOS PAC ID: 4880504596 Enrollment ID: O20031106000287 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
Affimed Therapeutics AG and The Leukemia & Lymphoma Society today announced a partnership to co-fund a phase 2 trial with the Recruit-TandAb AFM13, a novel tetravalent bispecific antibody directed against human CD30 and CD16A in Hodgkin Lymphoma patients for whom currently available treatments have failed.
Loads of studies over the years have shown that children who were breastfed score higher on IQ tests and perform better in school, but the reason why remained unclear.
Fewer Americans fear root canal treatment, according to a recent survey by the American Association of Endodontists. Just over half of those surveyed, 54 percent, said root canals make them apprehensive, down from 60 percent in 2013, and the lowest numbers reported since the AAE began its annual survey in 2011.
› Verified 7 days ago
| Entity Name | Wenatchee Valley Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669719688 PECOS PAC ID: 9537309869 Enrollment ID: O20130716000034 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
Affimed Therapeutics AG and The Leukemia & Lymphoma Society today announced a partnership to co-fund a phase 2 trial with the Recruit-TandAb AFM13, a novel tetravalent bispecific antibody directed against human CD30 and CD16A in Hodgkin Lymphoma patients for whom currently available treatments have failed.
Loads of studies over the years have shown that children who were breastfed score higher on IQ tests and perform better in school, but the reason why remained unclear.
Fewer Americans fear root canal treatment, according to a recent survey by the American Association of Endodontists. Just over half of those surveyed, 54 percent, said root canals make them apprehensive, down from 60 percent in 2013, and the lowest numbers reported since the AAE began its annual survey in 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lonnie Edward Dye Iii, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 662-1511 | Dr Lonnie Edward Dye Iii, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 662-1511 |
News Archive
REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.
Affimed Therapeutics AG and The Leukemia & Lymphoma Society today announced a partnership to co-fund a phase 2 trial with the Recruit-TandAb AFM13, a novel tetravalent bispecific antibody directed against human CD30 and CD16A in Hodgkin Lymphoma patients for whom currently available treatments have failed.
Loads of studies over the years have shown that children who were breastfed score higher on IQ tests and perform better in school, but the reason why remained unclear.
Fewer Americans fear root canal treatment, according to a recent survey by the American Association of Endodontists. Just over half of those surveyed, 54 percent, said root canals make them apprehensive, down from 60 percent in 2013, and the lowest numbers reported since the AAE began its annual survey in 2011.
› Verified 7 days ago
Deborah M. Witham, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
David C. Wiggum, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Jeb A. Sorom, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Garrett Wolter, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Rudy Wayne Linterman, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
John F. Colpitts, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Peter W. Valaas, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 |